Stock Screener App

Frei -

Installieren

2.35

2.62% 0.06

Cassava Sciences Inc (SAVA)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt SAVA? Forum Prognose Aktiensplit Dividendenhistorie

Cassava Sciences Inc Aktie (SAVA) Neueste Nachrichten

CASSAVA SCIENCES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Cassav - The Malaysian Reserve

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cassava Sciences, Inc. of Class Action Lawsuit and Upcoming DeadlinesSAVA - PR Newswire

SAVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cassava Sciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - GlobeNewswire Inc.

ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Cassava - GlobeNewswire

Class Action Filed Against Cassava Sciences, Inc. (SAVA)February 10, 2025 Deadline to JoinContact The Gross Law Firm - Longview News-Journal

Levi & Korsinsky Reminds Cassava Sciences, Inc. Investors - GlobeNewswire

SAVA Stock Plummets to 52-Week Low at $2.33 Amid Market Challenges - Investing.com

SAVA Investors Have Opportunity to Lead Cassava Sciences, Inc. Securities Fraud Lawsuit - The Malaysian Reserve

SAVA STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Cassava Sciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - AccessWire

SAVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cassava Sciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Business Wire

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cassava - PR Newswire

CASSAVA SCIENCES, INC. (NASDAQ: SAVA) INVESTOR ALERT: - GlobeNewswire

CASSAVA SCIENCES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Cassava Sciences, Inc. - GlobeNewswire Inc.

CASSAVA ALERT: Bragar Eagel & Squire, P.C. Announces that a - GlobeNewswire

ROSEN, A LONGSTANDING LAW FIRM, Encourages Cassava - GlobeNewswire

SAVA SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Cassava Sciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - AccessWire

Levi & Korsinsky Notifies Cassava Sciences, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineSAVA - Longview News-Journal

Investor Notice: Robbins LLP Informs Stockholders of the Class Action Lawsuit Filed Against Cassava Sciences, Inc. - PR Newswire

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Cassava Sciences, Inc. - EIN News

Cassava Sciences, Inc. Sued for Securities Law Violations – - GlobeNewswire

The Manufacturers Life Insurance Company Sells 7,458 Shares of Cassava Sciences, Inc. (NASDAQ:SAVA) - Defense World

Cassava Sciences, Inc. (NASDAQ:SAVA) Shares Sold by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World

SAVA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Cassava Sciences, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - AccessWire

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Cassava - GlobeNewswire

SAVA Investors with Losses in Excess of $100K Have Opportunity to Lead Cassava Sciences, Inc. Securities Fraud Lawsuit - The Malaysian Reserve

SAVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire

Rosen Law Firm Urges Cassava Sciences, Inc. (NASDAQ: SAVA) Stockholders with Large Losses in Excess of $100K to Contact the Firm for Information About Their Rights - The Bakersfield Californian

SHAREHOLDER ALERT: Class Action Lawsuit Filed on Behalf of - GlobeNewswire

SAVA SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Cassava Sciences, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - AccessWire

375,000 Shares in Cassava Sciences, Inc. (NASDAQ:SAVA) Bought by Tidal Investments LLC - MarketBeat

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors - GlobeNewswire

Lost Money on Cassava Sciences, Inc.(SAVA)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky LLP - TipRanks

Cassava Shares Sink as CEO Resigns From Troubled Biotech Company - MSN

SAVA Stock Plummets to 52-Week Low at $2.77 Amid Market Challenges By Investing.com - Investing.com South Africa

SAVA Stock Plummets to 52-Week Low at $2.77 Amid Market Challenges - Investing.com India

RIP simufilam, we hardly knew ye - Healthcare Brew

Bronstein, Gewirtz & Grossman, LLC Is Investigating Cassava Sciences, Inc. (SAVA) And Encourages Shareholders to Connect - AccessWire

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Cassava Sciences, Inc. (SAVA) And Encourages Shareholders to Reach Out - AccessWire

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Cassava Sciences, Inc. (SAVA) and Encourages Shareholders to Learn More About the Investigation - AccessWire

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Cassava Sciences, Inc. (SAVA) and Encourages Investors to Learn More About the Investigation - AccessWire

Cassava Sciences, Inc. (SAVA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - AccessWire

Cassava Sciences Stock Craters After Alzheimer’s Disease Trial Flops: Retail’s Devastated - MSN

SAVA Stock Plummets to 52-Week Low at $3.35 Amid Market Turbulence By Investing.com - Investing.com South Africa

SAVA Stock Plummets to 52-Week Low at $3.35 Amid Market Turbulence - Investing.com India

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cassava Sciences, Inc.SAVA - PR Newswire

Cassava Sciences: REFOCUS Unlikely To Save Simufilam, Careful Development Needed - Seeking Alpha

A Post-Mortem on Cassava Sciences - MSN

Down -83.93% in 4 Weeks, Here's Why You Should You Buy the Dip in Cassava Sciences (SAVA) - MSN

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Cassava Sciences, Inc. (SAVA) And Encourages Stockholders to Reach Out - AccessWire

HC Wainwright Has Negative Outlook of SAVA FY2024 Earnings - MarketBeat

SMMT

$17.87

2.88%

INCY

$68.84

2.65%

MRNA

$39.39

0.43%

UTHR

$359.58

0.16%

BGNE

$176.50

1.02%

BNTX

$113.08

1.56%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters